Targeting the HO-1/CO Pathway with Sanguinate: Toward Development of a Novel Anti-inflammatory Therapy for Cystic Fibrosis (CF) Lung Disease by Prolong Pharma | May 1, 2020 | Conferences
Resuscitation with PEGylated carboxyhemoglobin preserves renal cortical oxygenation and improves skeletal muscle microcirculatory flow during endotoxemia by Prolong Pharma | May 1, 2020 | Conferences
Targeting The Ho-1/Co Pathway To Ameliorate Lung Hyperinflammation In Cystic Fibrosis by Prolong Pharma | Oct 1, 2019 | Conferences
Current and Novel Preventive and Curative Interventions for the Treatment of Patients with Sickle Cell Disease by Prolong Pharma | Oct 1, 2018 | Conferences
Summary of the Interagency Oxygen Carrier State of the Science Meeting by Prolong Pharma | Jun 18, 2017 | Conferences